Cargando…

Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases

Objective: Sleep disorders are common in voltage-gated potassium channel complex antibody (VGKC-Ab) diseases. The aim was to investigate the sleep disturbances and polysomnography (PSG) characteristics in patients with VGKC-Ab-associated diseases. Methods: Twenty-seven patients with leucine-rich gli...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Nan, Hao, Honglin, Guan, Hongzhi, Sun, Heyang, Liu, Qing, Lu, Qiang, Jin, Liri, Ren, Haitao, Huang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406672/
https://www.ncbi.nlm.nih.gov/pubmed/32849186
http://dx.doi.org/10.3389/fneur.2020.00696
_version_ 1783567470912602112
author Lin, Nan
Hao, Honglin
Guan, Hongzhi
Sun, Heyang
Liu, Qing
Lu, Qiang
Jin, Liri
Ren, Haitao
Huang, Yan
author_facet Lin, Nan
Hao, Honglin
Guan, Hongzhi
Sun, Heyang
Liu, Qing
Lu, Qiang
Jin, Liri
Ren, Haitao
Huang, Yan
author_sort Lin, Nan
collection PubMed
description Objective: Sleep disorders are common in voltage-gated potassium channel complex antibody (VGKC-Ab) diseases. The aim was to investigate the sleep disturbances and polysomnography (PSG) characteristics in patients with VGKC-Ab-associated diseases. Methods: Twenty-seven patients with leucine-rich glioma-inactivated protein 1 antibody (LGI1-Ab) encephalitis, seven patients with contactin protein-like 2 antibody (Caspr2-Ab)-associated diseases, and 14 healthy controls with at least one PSG or actigraphy recording were recruited at Peking Union Medical College Hospital from January 2014 to July 2019. Results: Sleep disorders including insomnia, hypersomnia, rapid eye movement (REM) sleep behavior disorder (RBD), periodic limb movements in sleep (PLMS), agrypnia excitata, and obstructive sleep apnea syndrome were observed. Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). Of five patients with Caspr2-Ab-associated diseases, TST was found to be 329.5 (167.0–377.5 min), and sleep efficiency was found to be 61.7% (34.6–71.7%). The percentage for N3 and REM sleep was found to be 15.0% (0–34.6%) and 12.7% (0–22.2%), respectively. Both RBD and PLMS were observed more frequently in patients with LGI1-Ab encephalitis. We identified status dissociatus (SD) in five (23.8%) patients with LGI1-Ab encephalitis and two (40%) patients with Caspr2-Ab diseases. The former is more likely to have simple limb movements rather than complex movements, which mimic the contents of their dreams. Continuous insomnia was more common in patients with Caspr2-Ab diseases than patients with LGI1-Ab encephalitis. Patients reported clinical and PSG improvements following immunotherapy. Conclusion: Sleep disorders in patients with VGKC-Ab-associated diseases include decreased TST and poor sleep efficiency. Our studies provide evidence of SD in patients with LGI1-Ab encephalitis.
format Online
Article
Text
id pubmed-7406672
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74066722020-08-25 Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases Lin, Nan Hao, Honglin Guan, Hongzhi Sun, Heyang Liu, Qing Lu, Qiang Jin, Liri Ren, Haitao Huang, Yan Front Neurol Neurology Objective: Sleep disorders are common in voltage-gated potassium channel complex antibody (VGKC-Ab) diseases. The aim was to investigate the sleep disturbances and polysomnography (PSG) characteristics in patients with VGKC-Ab-associated diseases. Methods: Twenty-seven patients with leucine-rich glioma-inactivated protein 1 antibody (LGI1-Ab) encephalitis, seven patients with contactin protein-like 2 antibody (Caspr2-Ab)-associated diseases, and 14 healthy controls with at least one PSG or actigraphy recording were recruited at Peking Union Medical College Hospital from January 2014 to July 2019. Results: Sleep disorders including insomnia, hypersomnia, rapid eye movement (REM) sleep behavior disorder (RBD), periodic limb movements in sleep (PLMS), agrypnia excitata, and obstructive sleep apnea syndrome were observed. Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). Of five patients with Caspr2-Ab-associated diseases, TST was found to be 329.5 (167.0–377.5 min), and sleep efficiency was found to be 61.7% (34.6–71.7%). The percentage for N3 and REM sleep was found to be 15.0% (0–34.6%) and 12.7% (0–22.2%), respectively. Both RBD and PLMS were observed more frequently in patients with LGI1-Ab encephalitis. We identified status dissociatus (SD) in five (23.8%) patients with LGI1-Ab encephalitis and two (40%) patients with Caspr2-Ab diseases. The former is more likely to have simple limb movements rather than complex movements, which mimic the contents of their dreams. Continuous insomnia was more common in patients with Caspr2-Ab diseases than patients with LGI1-Ab encephalitis. Patients reported clinical and PSG improvements following immunotherapy. Conclusion: Sleep disorders in patients with VGKC-Ab-associated diseases include decreased TST and poor sleep efficiency. Our studies provide evidence of SD in patients with LGI1-Ab encephalitis. Frontiers Media S.A. 2020-07-30 /pmc/articles/PMC7406672/ /pubmed/32849186 http://dx.doi.org/10.3389/fneur.2020.00696 Text en Copyright © 2020 Lin, Hao, Guan, Sun, Liu, Lu, Jin, Ren and Huang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Lin, Nan
Hao, Honglin
Guan, Hongzhi
Sun, Heyang
Liu, Qing
Lu, Qiang
Jin, Liri
Ren, Haitao
Huang, Yan
Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases
title Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases
title_full Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases
title_fullStr Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases
title_full_unstemmed Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases
title_short Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases
title_sort sleep disorders in leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated diseases
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406672/
https://www.ncbi.nlm.nih.gov/pubmed/32849186
http://dx.doi.org/10.3389/fneur.2020.00696
work_keys_str_mv AT linnan sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases
AT haohonglin sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases
AT guanhongzhi sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases
AT sunheyang sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases
AT liuqing sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases
AT luqiang sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases
AT jinliri sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases
AT renhaitao sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases
AT huangyan sleepdisordersinleucinerichgliomainactivatedprotein1andcontactinproteinlike2antibodyassociateddiseases